CBD oil: a hidden danger for transplant patients?
NCT ID NCT05490511
Summary
This study looked at how CBD oil interacts with tacrolimus, a critical anti-rejection drug for transplant recipients. Researchers tested 57 healthy volunteers and people with chronic kidney disease to see if CBD changes how the body processes the medication. The goal is to provide doctors with clear guidance on whether to avoid CBD or adjust drug doses to prevent harmful side effects and improve transplant success.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY DISEASE, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IU Health University Hospital
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.